However, PLGA-PEG-B6/Cur nanoparticles could remarkably improve the cognitive impairment in APP/PS1 mice, which would be of potential use in Alzheimer’s disease. This evidence concerns the gene APP and early-onset autosomal dominant Alzheimer disease.